Cargando…

A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is the leading inheritable cause of end-stage renal disease (ESRD); however, the natural course of disease progression is heterogeneous between patients. This study aimed to develop a natural history model of ADPKD that predicted progr...

Descripción completa

Detalles Bibliográficos
Autores principales:	McEwan, Phil, Bennett Wilton, Hayley, Ong, Albert C. M., Ørskov, Bjarne, Sandford, Richard, Scolari, Francesco, Cabrera, Maria-Cristina V., Walz, Gerd, O’Reilly, Karl, Robinson, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810027/ https://www.ncbi.nlm.nih.gov/pubmed/29439650 http://dx.doi.org/10.1186/s12882-017-0804-2

Ejemplares similares

Modelling the long-term benefits of tolvaptan therapy on renal function decline in autosomal dominant polycystic kidney disease: an exploratory analysis using the ADPKD outcomes model
por: Bennett, Hayley, et al.
Publicado: (2019)

European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care: European ADPKD Forum and Multispecialist Roundtable participants
por: Harris, Tess, et al.
Publicado: (2018)

Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)
por: Sans-Atxer, Laia, et al.
Publicado: (2013)

Cellular abnormalities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) fibroblasts
por: Moyes, S, et al.
Publicado: (2012)

Echocardiographic Abnormalities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients
por: Pfeferman, Mariana Becker, et al.
Publicado: (2022)

Informatics-guided drug repurposing for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Kiseleva, Anna A., et al.
Publicado: (2020)

Systems biology approaches toward autosomal dominant polycystic kidney disease (ADPKD)
por: Rahimmanesh, Ilnaz, et al.
Publicado: (2020)

Management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) During Pregnancy: Risks and Challenges
por: McBride, Lucy, et al.
Publicado: (2020)

Clinical Utility and Tolerability of Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Raina, Rupesh, et al.
Publicado: (2022)

Recurrent Cholangitis in a Patient with Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Caroli's Disease
por: Hasegawa, Eiko, et al.
Publicado: (2016)

Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD)
por: Dudley, Jan, et al.
Publicado: (2019)

Association of Vitamin D Levels With Kidney Volume in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Vendramini, Larissa Collis, et al.
Publicado: (2019)

Bone health in autosomal dominant polycystic kidney disease (ADPKD) patients after kidney transplantation
por: Zubidat, Dalia, et al.
Publicado: (2023)

Bilineal inheritance of type 1 autosomal dominant polycystic kidney disease (ADPKD) and recurrent fetal loss
por: Peces, Ramón, et al.
Publicado: (2008)

Native Nephrectomy before and after Renal Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Maxeiner, Andreas, et al.
Publicado: (2019)

The Effect of Dietary Intervention on Autosomal-Dominant Polycystic Kidney Disease (ADPKD) Patients on Tolvaptan and Their Quality of Life
por: Tarabzuni, Ola
Publicado: (2022)

Outcomes from the Northeast England cohort of autosomal dominant polycystic kidney disease (ADPKD) patients on tolvaptan
por: Gkekas, Eleftherios, et al.
Publicado: (2022)

Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Carrera, Paola, et al.
Publicado: (2016)

Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Sekine, Akinari, et al.
Publicado: (2022)

The prevalence of autosomal dominant polycystic kidney disease (ADPKD): A meta-analysis of European literature and prevalence evaluation in the Italian province of Modena suggest that ADPKD is a rare and underdiagnosed condition
por: Solazzo, Andrea, et al.
Publicado: (2018)

Autosomal dominant polycystic kidney disease (ADPKD) is associated with coronary arterial dilatation in end-stage renal failure patients
por: Chiha, Joseph, et al.
Publicado: (2012)

Case report: tolvaptan-associated creatine kinase elevation in two patients with autosomal dominant polycystic kidney disease (ADPKD)
por: Agraz-Pamplona, I., et al.
Publicado: (2020)

Total and Extracellular Vesicle cAMP Contents in Urine Are Associated with Autosomal Dominant Polycystic Kidney Disease (ADPKD) Progression
por: Rosenberg, María Lucía, et al.
Publicado: (2023)

A Rare Case of Pelvic Organ Prolapse in a Nulliparous Female With Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Polycystic Liver Disease (PLD)
por: Hechter, Sharon, et al.
Publicado: (2021)

Pretransplant Nephrectomy for Large Polycystic Kidneys in ADPKD (Autosomal Dominant Polycystic Kidney Disease) Patients: Is Peritoneal Dialysis Recovery Possible after Surgery?
por: Ietto, Giuseppe, et al.
Publicado: (2019)

Isolated Persistent Left Superior Vena Cava Associated With Autosomal Dominant Polycystic Kidney Disease (ADPKD): Challenges and Clinical Significance
por: Samara, Osama A, et al.
Publicado: (2022)

Life-Threatening Retroperitoneal Hemorrhage Following Cyst Rupture in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Case Report
por: Duriseti, Parikshit, et al.
Publicado: (2023)

Polycystins, ADPKD, and Cardiovascular Disease
por: Kuo, Ivana Y., et al.
Publicado: (2019)

Heterogeneous Cardiovascular Profiles in CKD: ADPKD Versus non-ADPKD
por: Au, Eric H.K., et al.
Publicado: (2022)

Rationale and study protocol of ACQUIRE, a prospective, observational study measuring quality of life, treatment preference and treatment satisfaction of autosomal dominant polycystic kidney disease (ADPKD) patients in Europe
por: Joly, Dominique, et al.
Publicado: (2020)

ARPKD and early manifestations of ADPKD: the original polycystic kidney disease and phenocopies
por: Bergmann, Carsten
Publicado: (2014)

Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study
por: Serra, Andreas L, et al.
Publicado: (2007)

Antenatally Diagnosed ADPKD
por: Aldridge, Melanie, et al.
Publicado: (2018)

Intrafamilial Variability of ADPKD
por: Lanktree, Matthew B., et al.
Publicado: (2019)

Identification and Characterization of Novel Mutations in Chronic Kidney Disease (CKD) and Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Saudi Subjects by Whole-Exome Sequencing
por: Alzahrani, Othman R., et al.
Publicado: (2022)

Kidney transplantation with concomitant simple nephrectomy by thoracoabdominal approach for patients with huge autosomal dominant polycystic kidney disease (ADPKD): A case report
por: Yamada, Yasutoshi, et al.
Publicado: (2019)

Incoercible Vomiting in a Polycystic (ADPKD) Patient on Peritoneal Dialysis
por: Burguera Vion, Victor, et al.
Publicado: (2021)

Influence of angiotensin converting enzyme (ACE) gene rs4362 polymorphism on the progression of kidney failure in patients with autosomal dominant polycystic kidney disease (ADPKD)
por: Ramanathan, Gnanasambandan, et al.
Publicado: (2016)

Early Urinary Biomarkers in Pediatric Autosomal Dominant Polycystic Kidney Disease (ADPKD): No Evidence in the Interest of Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL)
por: Tsingos, Marianthi, et al.
Publicado: (2019)

Idiosyncratic hepatic toxicity in autosomal dominant polycystic kidney disease (ADPKD) patient in combined treatment with tolvaptan and amoxicillin/clavulanic acid: a case report
por: Pellegrino, Angela Maria, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_51h1pe8vrs011625m01isgsftn